Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SYH2068 in Adults With Elevated Lipoprotein(a)
NCT07640217Phase 2Not yet recruiting
- Sponsor
- CSPC Zhongnuo Pharmaceutical
- Start
- Jul 2026
- Primary completion
- Mar 2028
01
Overview
A Phase 2 trial of SYH2068 in elevated lipoprotein(a) (Lp(a)), sponsored by CSPC Zhongnuo Pharmaceutical. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
SYH2068
03
Conditions
elevated lipoprotein(a) (Lp(a))
Beyond the preview
Go deeper on NCT07640217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07640217.